Skip to content

ROLE OF LIQUID PARAFFIN IN THE PATIENTS OF ADHESIVE INTESTINAL OBSTRUCTION

therapeutic value of liquid paraffin in the treatment of adhesive small bowel obstrution

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012633
Enrollment
170
Registered
2018-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Liquid paraffin with standard conservative managment: participants are given 30ml liquid paraffin to take orally twice daily in addition to standard care Control Intervention1: standard

Sponsors

Holy Family Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. Previous abdominal surgery conducted more than 4 weeks before enrolment B. One of the following radiological criteria: 1. A plain abdominal radiograph taken with the patient upright that showed dilated loops of the small intestine, air fluid levels and gas in the colon, indicating a partial SBO. 2. Ultrasound abdomen/CECT abdomen shows dilated bowel loops with hyper peristalsis without any free fluid or any other pathology.

Exclusion criteria

Exclusion criteria: Age: less than 12 years sex: both sex included 1. Pregnancy. 2. One or more signs suggestive of intestinal strangulation or peritonitis such as rigidity, absent bowel sound, gas under diaphragm, intractable pain, and tachycardia. 3. Patients with documented or suspected intraabdominal malignancy. 4. Hemodynamically unstable patients. 5. Patients with irreducible abdominal hernia. 6. Patients with previous history of OR active abdominal tuberculosis 7. Patients of Crohns disease 8. Palpable intraabdominal lump. 9. Ultrasound abdomen or CECT abdomen suggestive of any other abdominal pathology 10. Prior abdominal irradiation 11. The abdominal radiograph showed no gas in the colon

Design outcomes

Primary

MeasureTime frame
ability to tolerate diet and return of normal bowel functionTimepoint: recorded at baseline and at every 12 hours

Secondary

MeasureTime frame
Abdominal distension and Air-fluid levels are measured using an abdominal radiographTimepoint: at baseline and 24, 48, 72, 96 and 120 hours

Countries

India

Contacts

Public ContactDr lokesh arora

Holy Family Hospital, New Delhi

drpchadha@rediffmail.com9716832354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026